UK markets open in 37 minutes
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,478.90 -99.40 (-0.54%) CRUDE OIL
78.61 +0.13 (+0.17%) GOLD FUTURES
2,328.50 -2.70 (-0.12%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,687.84 -608.18 (-1.19%)
Aytu BioPharma, Inc. (AYTU)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.0100 |
| Open | 3.0900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.0400 - 3.1700 |
| 52-week range | 1.3800 - 3.5000 |
| Volume | |
| Avg. volume | 21,338 |
| Market cap | 17.037M |
| Beta (5Y monthly) | -1.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript February 14, 2024 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the […]
- Simply Wall St.
Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
Aytu BioPharma ( NASDAQ:AYTU ) Second Quarter 2024 Results Key Financial Results Revenue: US$22.9m (down 13% from 2Q...
- Thomson Reuters StreetEvents
Q2 2024 Aytu Biopharma Inc Earnings Call
Q2 2024 Aytu Biopharma Inc Earnings Call
© 2024 Yahoo. All rights reserved.